A pilot study of dehydroepiandrosterone sulfate in myotonic dystrophy

Neurology

Volumn 51, Issue 2, 1998, Pages 586-589

  Sugino, M ^a   Ohsawa, N ^a   Ito, T ^a   Ishida, S ^a   Yamasaki, H ^a   Kimura, F ^a   Shinoda, K ^a  

^a OSAKA MEDICAL COLLEGE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

PRASTERONE SULFATE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DAILY LIFE ACTIVITY; DRUG EFFECT; EXTRASYSTOLE; FEMALE; HEART BLOCK; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; MUSCLE STRENGTH; MYOTONIA; MYOTONIC DYSTROPHY; PRIORITY JOURNAL;

EID: 0031753630     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.51.2.586     Document Type: Article

References (10)

1. Orentreich N, Brind JL, Rizer RL, Vogelman JH. Age changes and sex differences in serum dehydroepiandrosterone sulfate concentrations throughout adulthood. J Clin Endocrinol Metab 1984;59:551-555.
2. Carter JN, Steinbeck KS. Reduced adrenal androgens in patients with myotonic dystrophy. J Clin Endocrinol Metab 1985;60:611-614.
3. Ahlskong JE, Aksamit AJ, Aronson AE, et al. Motor function. Part II: specific study of muscle. In: Members of the Department of Neurology, Mayo Clinic Foundation for Medical Education and Research. Clinical examinations in neurology (6th ed.). St. Louis, MO: Mosby Year Book, 1991: 174-239.
4. Fu Y-H, Pizzuti A, Fenwick RG Jr, et al. An unstable triplet repeat in a gene related to myotonic muscular dystrophy. Science 1992;255:1256-1258.
5. Brook JD, MaCurrach ME, Harley HG, et al. Molecular basis of myotonic dystrophy: expansion of a trinucleotide (CTG) repeat at the 3′ end of a transcript encoding a protein kinase family member. Cell 1992;68:799-808.
6. Vlachopapadopoulou E, Zachwieja JJ, Gertner JM, et al. Metabolic and clinical response to recombinant human insulin-like growth factor I in myotonic dystrophy - A clinical research center study. J Clin Endocrinol Metab 1995;80:3715-3723.
7. Munsat TL. Therapy of myotonia. A double-blind evaluation of diphenylhydantoin, procainamide, and placebo. Neurology 1967;17:359-367.
8. Durelli L, Mutani R, Fassio F. The treatment of myotonia: evaluation of chronic oral taurine therapy. Neurology 1983;33: 599-603.
9. Pouget J, Serratrice G. Myotonie avec faiblesse musculaire corrigée par l'exercice. Effet thérapeutique de la mexilétine. Rev Neurol (Paris) 1983;139:665-672.
10. Griggs RC, Pandya S, Florence JM, et al. Randomized controlled trial of testosterone in myotonic dystrophy. Neurology 1989;39:219-222.